Concepedia

Victoria Luchenko

VL

Statistics

Publications

9

Citations

433

H-Index

9

Active since

2008

Affiliations

National Institutes of Health(Current)

Center for Cancer Research

National Cancer Institute

National Institutes of Health Clinical Center

Victoria Luchenko is an author at National Institutes of Health specializing in medicine, pharmacology, and cancer research.

Top concepts

Publications per year

2008–2016

9

Publications

9

MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor

Arup R. Chakraborty, Robert W. Robey, Victoria Luchenko et al. · Blood · 2013 · 85 citations · Full text

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T‐cell lymphoma

Susan E. Bates, Zhirong Zhan, Kenneth Steadman et al. · British Journal of Haematology · 2009 · 77 citations · Full text

, , +17

Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers

Laleh Amiri‐Kordestani, Victoria Luchenko, Cody J. Peer et al. · Clinical Cancer Research · 2013 · 65 citations · Full text

Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer

Victoria Luchenko, Crystal D. Salcido, Yongwei Zhang et al. · Cell Cycle · 2011 · 49 citations

, , +22

Histone deacetylase inhibitor‐mediated cell death is distinct from its global effect on chromatin

Victoria Luchenko, Thomas Litman, Arup R. Chakraborty et al. · Molecular Oncology · 2014 · 47 citations · Full text

1–5 of 9